Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Symptomatic Ischemic Heart Disease”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableLooking for participantsNCT04634240
What this trial is testing

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

Who this might be right for
Aortic StenosisCoronary Artery DiseaseCoronary Stenosis
University of British Columbia 4,000
Not applicableUnknownNCT00172458
What this trial is testing

Clinical Results and Restenosis Analysis of Symptomatic Ostial Vertebral Artery Stenosis Treated With Tubular Coronary Stents

Who this might be right for
Vertebral Artery Stenosis
National Taiwan University Hospital
Large-scale testing (Phase 3)Study completedNCT00974181
What this trial is testing

The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)

Who this might be right for
Treatment of Symptomatic Ischemic Heart Disease
Cordis US Corp. 282
Large-scale testing (Phase 3)Study completedNCT00091429
What this trial is testing

Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine

Who this might be right for
Angina
Gilead Sciences 500
Testing effectiveness (Phase 2)Looking for participantsNCT06705023
What this trial is testing

Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.

Who this might be right for
Myocardial InjuryLV DysfunctionCoronary Artery Disease+1 more
Ralf Rothoerl 36
Not applicableNot Yet RecruitingNCT06953778
What this trial is testing

The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome

Who this might be right for
Atrial Fibrillation
VA Office of Research and Development 24,060
Not applicableWithdrawnNCT03804125
What this trial is testing

Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Who this might be right for
Cerebral StrokeThrombosis, Deep VeinPulmonary Embolism
Pfizer
Early research (Phase 1)Looking for participantsNCT05762952
What this trial is testing

Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease

Who this might be right for
Myocardial Ischemia
University of Virginia 40
Not applicableActive Not RecruitingNCT06991322
What this trial is testing

Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) (SERRA-I Study)

Who this might be right for
Coronary Microvascular DysfunctionCoronary Microvascular Disease
VahatiCor, Inc. 30
Not applicableLooking for participantsNCT07449325
What this trial is testing

Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)

Who this might be right for
Angina PectorisMyocardial IschemiaHeart Diseases+3 more
VahatiCor, Inc. 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07118449
What this trial is testing

Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABG

Who this might be right for
Coronary Artery Disease (CAD)
XyloCor Therapeutics, Inc. 116
Not applicableUnknownNCT06298045
What this trial is testing

Effectiveness of a Combination of Trimetazidine With One Hemodynamic Agent in Patients Recently Diagnosed With Stable Angina and Still Symptomatic Despite First Line Hemodynamic Therapy

Who this might be right for
Stable Angina
Servier Affaires Médicales 600
Post-approval studies (Phase 4)Looking for participantsNCT04416581
What this trial is testing

Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

Who this might be right for
Coronary Artery DiseasePercutaneous Coronary InterventionAcute Coronary Syndrome+1 more
Duk-Woo Park, MD 3,320
Post-approval studies (Phase 4)Study completedNCT00128024
What this trial is testing

Effects of Early Statin Treatment After Acute Myocardial Infarction (AMI) in Japanese Patients

Who this might be right for
Myocardial Infarction
Kumamoto University 460
Not applicableActive Not RecruitingNCT06713239
What this trial is testing

Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD

Who this might be right for
Coronary Artery Disease
Cleerly, Inc. 1,000